Parsons Capital Management Inc. RI reduced its stake in shares of CME Group Inc (NASDAQ:CME) by 5.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,949 shares of the financial services provider’s stock after selling 605 shares during the quarter. Parsons Capital Management Inc. RI’s holdings in CME Group were worth $2,125,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Dimensional Fund Advisors LP grew its holdings in CME Group by 2.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 906,174 shares of the financial services provider’s stock worth $170,463,000 after acquiring an additional 24,717 shares in the last quarter. Geode Capital Management LLC grew its holdings in CME Group by 12.9% during the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after acquiring an additional 537,917 shares in the last quarter. Truvestments Capital LLC bought a new position in CME Group during the 1st quarter worth about $32,000. Mercer Global Advisors Inc. ADV bought a new position in CME Group during the 1st quarter worth about $392,000. Finally, Virtu Financial LLC bought a new stake in shares of CME Group in the 1st quarter valued at about $635,000. Institutional investors and hedge funds own 84.44% of the company’s stock.
In related news, Director Howard J. Siegel sold 5,000 shares of CME Group stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $205.00, for a total value of $1,025,000.00. Following the completion of the sale, the director now directly owns 80,382 shares in the company, valued at approximately $16,478,310. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Dennis Suskind sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $212.46, for a total transaction of $318,690.00. Following the transaction, the director now directly owns 4,853 shares of the company’s stock, valued at $1,031,068.38. The disclosure for this sale can be found here. Insiders sold a total of 82,363 shares of company stock valued at $16,429,225 over the last quarter. 1.20% of the stock is owned by company insiders.
CME stock traded up $3.63 during trading on Thursday, reaching $211.98. The company had a trading volume of 697,064 shares, compared to its average volume of 1,342,918. The business has a 50-day simple moving average of $203.69. The firm has a market cap of $75.78 billion, a P/E ratio of 31.08, a price-to-earnings-growth ratio of 4.73 and a beta of 0.23. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $216.73.
CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The company had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s revenue for the quarter was up 20.1% on a year-over-year basis. During the same period last year, the business earned $1.74 EPS. As a group, analysts expect that CME Group Inc will post 6.68 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
A number of analysts have recently weighed in on CME shares. Wells Fargo & Co raised their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. Deutsche Bank raised their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Rosenblatt Securities cut shares of CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. ValuEngine upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Finally, BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 9th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $194.00.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Read More: Momentum Indicators
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.